TTRX Turn Therapeutics Inc.
Healthcare$5.36+4.48%ClosedMarket Cap: $159.7M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
24.72
P/S
0.00
EV/EBITDA
-22.10
DCF Value
$0.18
FCF Yield
-2.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-116.8%
ROA
-20.6%
ROIC
-49.6%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | -Infinity% | $-1.2M | $-971.0K | $— | — |
| Q4 null | $0.00 | -Infinity% | $-2.2M | $279.1K | $— | — |
| FY null | $0.00 | NaN% | $-5.9M | $-3.2M | $— | — |
| Q3 null | $0.00 | -Infinity% | $-1.9M | $-1.9M | $— | — |
| Q2 null | $0.00 | NaN% | $-1.4M | $-1.2M | $— | — |
| FY null | $0.00 | NaN% | $-1.8M | $-1.8M | $— | — |
| Q2 null | $0.00 | NaN% | $-360.2K | $-351.9K | $— | — |
| FY null | $0.00 | NaN% | $-2.3M | $-2.3M | $— | — |